Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Solvias, a large independent analytical testing, contract research, development and manufacturing company, announced that it has acquired Canton, Mass.-based Chemic Laboratories, Inc. (Chemic). With this acquisition, Solvias gains a strong foothold ...
read more
Sorrel Medical announced the opening of a new manufacturing facility with state-of-the-art cleanroom facilities to accommodate manufacturing scalability of its wearable drug delivery devices.
read more
Sorrel Medical has entered into a strategic partnership with pharmaceutical companies to advance the development and introduction of next-generation wearable drug delivery solutions.
read more
Monday, December 30, 2019
Sosei Group has been notified by its strategic alliance partner Pfizer that it has nominated a third clinical candidate from the multi-target drug discovery collaboration between the two companies.
read more
SP Scientific Products (SP) announces that to stay ahead of the ever-increasing global demand for its state-of-the-art fill-finish and lyophilization (freeze dryer) equipment, it has more than doubled its worldwide manufacturing capacity. Central to ...
read more
SPT Labtech, a laboratory automation solutions company for the life sciences industry, announced that David Newble has been appointed CEO, stepping up from his previous position as Managing Director. In his new capacity, he takes responsibility for ...
read more
Friday, December 22, 2017
SSCI has increased capacity in response to industry demand for the company’s cGMP particle characterization services by implementing Malvern’s next-generation laser diffraction instrument Mastersizer 3000.
read more
Friday, December 01, 2017
At the FDA, we’re vigilant about helping address the challenges that remain.
read more
As part of our public health mission, the FDA monitors the pharmaceutical supply chain to support patient access to medically necessary drugs.
read more
Friday, November 17, 2017
Update on the efforts by the FDA to address IV fluid shortages exacerbated by Hurricane Maria and advice for hospitals in managing the shortage.
read more
Wednesday, February 14, 2018
Additional resources will help advance initiatives to support novel medical technology and public health priorities such as generic drug development, pharmacy outsourcing and novel domestic manufacturing capabilities.
read more
Wednesday, September 05, 2018
Over the past 25 years, globalization of drug manufacturing has prompted the FDA to change its regulatory landscape.
read more
We’ve long recognized that compounded drugs can serve an important role for patients whose medical needs cannot be met by an FDA-approved drug product.
read more
Friday, February 22, 2019
Assessing and mitigating risks is at the heart of everything we do across our vast portfolio.
read more
Thursday, December 27, 2018
The day before a planned Georgia General Assembly House study committee meeting, the Kratom Trade Association said it is reaching out to state lawmakers to directly resolve their concerns about kratom.
read more